Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S(2024) First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial Br J Cancer(in press) DOI 10.1038/s41416-024-02696-6, PubMed 38664577
Foote JB, Mattox TE, Keeton AB, Chen X, Smith FT, Berry KL, Holmes T, Wang J, Huang CH, Ward AB, Hardy C, Fleten KG, Flatmark K, Yoon KJ, Sarvesh S, Ganji PN, Maxuitenko Y, Valiyaveettil J, Carstens JL, Buchsbaum DJ, Yang J, Zhou G, Nurmemmedov E, Babic I, Gaponenko Vet al.(2024) A Novel Pan-RAS Inhibitor with a Unique Mechanism of Action Blocks Tumor Growth in Mouse Models of GI Cancer bioRxiv DOI 10.1101/2023.05.17.541233, PubMed 38328254
López JI, Hogan MF, Sutton B, Church SE, Angulo JC, Nunes-Xavier CE(2023) Distinct spatial landscapes in clear-cell renal cell carcinoma as revealed by whole transcriptome analysis Immunooncol Technol, 21, 100690 DOI 10.1016/j.iotech.2023.100690, PubMed 38292905
